Finally out!
Happy to share our study on HHV6 reactivation after haploidentical HCT.
Our findings endorse the safety of combining ATG and PTCy. The main risk factor for HHV6 reactivation was a low lymphocyte count at day 30 after HCT.
ARTICLE👉chi.scholasticahq.com/article/92525 Mohamad Mohty
HHV6 Myocarditis Requiring Cardiac Transplant ➡️ jacc.org/doi/10.1016/j.… #JACCCaseReports JACC Journals Minnow Walsh, MD, MACC Tabitha Moe MD, FACC